A 5-Day outpatient regimen of 5-Azacitidine is well-tolerated and effective for high-risk81myelodysplastic syndrome and Acute Myeloid Leukemia patients unsuitablefor aggressive chemotherapy
Year: 2011
Type: conference-paper
Authors: Martin O’Reilly, Cliona M. McHale, Patrick Thornton, Philip Murphy, JA Quinn, Pamela Evans, Helen Enright
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W829940311